Navigation Links
Drug for Cancer to be on Pharmaceutical Benefits Scheme

The Federal Government and drug company, Roche are conducting talks to make the expensive anti-cancer treatment, Herceptin more widely available.//

According to Health Minister Tony Abbott discussions with manufacturer Roche has caused the delay in rushing Herceptin on to the Pharmaceutical Benefits Scheme (PBS).

Mr Abbott said,'It is important the Government try to get the best possible deal for taxpayers as well as the best possible deal for patients. So we are to some extent at least dependent on discussions with Roche, the company which makes the drug.'

Mortality rate caused by some types of breast cancer appears to be reduced with Herceptin. However the drug, which costs $50,000 to $60,000 per patient each year, is far too expensive for some victims.

The Government would have to spend about $100 million per year by listing Herceptin on the PBS but it would serve to make this drug more widely available.

According to Mr Abbot the listing of Herceptin was moving ahead more quickly than any other drug since he had become Health Minister.

He said, 'The Government has been pursuing this as quickly as possible. We expedited the consideration of Herceptin by the Therapeutic Goods Administration. We expedited the consideration by the Pharmaceutical Benefits Advisory Committee, and it will now get expedited consideration by Cabinet.'

The drug's benefits lie in reducing the chance of cancer reoccurring in women with a particular type of early-stage breast cancer.

If the Government accepts the recommendation of the Pharmaceutical Benefits Advisory Committee, the drug would be available to around 2100 patients for a subsidized price rather than the current cost.


'"/>




Page: 1

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... , ... March 28, 2017 , ... ... Tri-State Camp Conference in Atlantic City March 13-16, was a busy spot this ... of professional staff discussed strategies for preventing outbreaks among camp communities during the ...
(Date:3/28/2017)... ... March 28, 2017 , ... Oily skin is a common and unwelcomed occurrence in ... has a lot to offer to the discussion of dealing with excess skin oil. ... there are many home remedies that can help remove the oily shine while keeping the ...
(Date:3/28/2017)... ... , ... “A Prophets Bones”: a thrilling adventure that reveals the mystery of Kevin’s purpose. “A ... his parents and teachers had asked of him that he had neglected to do, but ... the Almighty Creator. There were some who would have felt themselves to be special and ...
(Date:3/27/2017)... ... 27, 2017 , ... The respected dental team at Northwood ... without the extensive time commitment and aesthetic disadvantages of traditional braces can now ... custom-designed series of virtually invisible aligners are created for each patient and crafted ...
(Date:3/27/2017)... Plains, NY (PRWEB) , ... March 27, 2017 , ... ... Root Canal Awareness Week by teaching their patients about the key role this treatment ... therapy from an experienced endodontist. To better serve those who need a root ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , March 28, 2017  AcelRx Pharmaceuticals, ... on the development and commercialization of innovative therapies ... that the European Medicines Agency (EMA) has notified ... 30 mcg) Marketing Authorisation Application (MAA) has passed ... MAA is underway. The MAA for ARX-04 (known ...
(Date:3/28/2017)... SAN FRANCISCO , March 28, 2017 ... is expected to reach USD 8.0 billion by 2025, ... Inc. The increasing incidence of infectious diseases and cancer ... for use in disease diagnosis over the coming years. ... the usage of autologous and allogenic stem cell therapy, ...
(Date:3/27/2017)... 2017 Summary This report ... and its partnering interests and activities since 2010. Description ... in-depth insight into the partnering activity of one of the ... reports are prepared upon purchase to ensure inclusion of the ... The report will be delivered in PDF format within 1 ...
Breaking Medicine Technology: